1-6 of 6
Sharif S. Khan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2a Study of SLS009, a Highly Selective CDK9 Inhibitor, in Combination with Azacitidine and Venetoclax for Relapsed/Refractory Acute Myeloid Leukemia after Prior Venetoclax Treatment

Joshua F Zeidner, Omer Jamy, Bradley Christensen, Sharif S. Khan, Dragan Cicic, Tapan M. Kadia
Journal: Blood
Blood (2024) 144 (Supplement 1): 2877.
https://doi.org/10.1182/blood-2024-198686
Published: 2024
Journal Articles

Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma

Deborah A. Katz, MD, Michael P. Chu, Kevin A. David, MD, Catherine Thieblemont, MD PhD, Nicholas J. Morley, Sharif S. Khan, Yuqi Chen, James Kalabus, Joan Morris, Abraham Anderson, Ariel A. Avilion, Eva González-Barca, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4077.
https://doi.org/10.1182/blood-2019-121708
Published: 2019
Journal Articles

Adolescent and Young Adult Leukemia and Lymphoma Care Delivery in the Community: Metrics and Outcomes of a Community-Based, Immersive AYA Program

Hal E Crosswell, MD, Fahd Quddus, MD, Sharif S. Khan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4733.
https://doi.org/10.1182/blood-2018-99-111526
Published: 2018
Journal Articles

A Phase 2 Study of Actinium-225 ( 225 Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µci/Kg/Dose

Ehab L. Atallah, MD, Johnnie J. Orozco, MD PhD, Michael Craig, MD, Moshe Yair Levy, MD, Laura E. Finn, MD, Sharif S. Khan, MD, Alexander E. Perl, MD, Jae H. Park, MD, Gail J. Roboz, MD, William Tse, MD, Kebede H. Begna, MD, Raya Mawad, MD, David A. Rizzieri, MD, Mark S. Berger, MD, Joseph G. Jurcic, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1457.
https://doi.org/10.1182/blood-2018-99-111951
Published: 2018
Journal Articles

Efficacy of 90Y-Ibritumomab Tiuxetan in the Older Population with Non-Hodgkin Lymphoma Pre-Treated with Rituximab-Based Regimens: A Single-Institution Experience

Vaibhav Agrawal, MD MBA, Smelser T. Diane, PhD, Jose I. Castillo, MD, Kelly Raup, RN, Girton D. Treanna, RN, Scotty R. Collins, MD, James O. Brady, MD, Sharif S. Khan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4066.
https://doi.org/10.1182/blood.V130.Suppl_1.4066.4066
Published: 2017
Journal Articles

Effect of the CEP72 Genotype and CYP3A5-Mediated Metabolism in Predicting Vincristine-Associated Peripheral Neuropathy

Vaibhav Agrawal, MD, M.B.A., Diane T. Smelser, PhD, David J. Carey, PhD, Joseph J. Vadakara, MD, Sharif S. Khan, MD
Journal: Blood
Blood (2016) 128 (22): 5963.
https://doi.org/10.1182/blood.V128.22.5963.5963
Published: 2016